Vir Biotechnology Inc. Revenue 2017–2025
Vir Biotechnology Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Vir Biotechnology Inc. revenue for the quarter ending March 31, 2026 was -29000, a 100.96% decrease year-over-year.
- Vir Biotechnology Inc. revenue for the twelve months ending March 31, 2026 was 4.5 M, a 93.09% decrease year-over-year.
- Vir Biotechnology Inc. annual revenue for 2025 was 68.6 M, a 7.61% decrease from 2024.
- Vir Biotechnology Inc. annual revenue for 2024 was 74.2 M, a 13.90% decrease from 2023.
- Vir Biotechnology Inc. annual revenue for 2023 was 86.2 M, a 94.67% decrease from 2022.
- Vir Biotechnology Inc. annual revenue for 2022 was 1.6 B.
Vir Biotechnology Inc. (VIR) — Frequently Asked Questions
Vir Biotechnology Inc. (VIR) is a publicly traded US company. It has a market capitalization of $1.14B. In fiscal 2025 it reported revenue of $69M and net income of -$438M. Explore VIR's stock price, financial statements, earnings history, margins and key ratios below.
What is Vir Biotechnology Inc.'s market cap?
Vir Biotechnology Inc. (VIR) has a market capitalization of $1.14B.
What is the VIR stock price?
VIR trades at $8.25 (-3.06% on the day).
How much revenue does Vir Biotechnology Inc. make?
Vir Biotechnology Inc. reported revenue of $69M in fiscal 2025.
Is VIR profitable?
In fiscal 2025, Vir Biotechnology Inc. reported net income of -$438M.